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Spinal muscular atrophy (SMA) is a recessive disorder involving the degradation 
and subsequent loss of motor neurons from the spinal cord. The main cause of SMA 
is related with the absence of the functional form of the survival motor neuron (SMN) 
gene (SMN1). This gene presents a telomeric (SMN1) and a centromeric (SMN2) 
copies that differ in 5 nucleotides. This mutation produces an alternative splicing of 
SMN2 giving rise to a truncated protein with reduced functionality (1,2). All the SMA 
patients have at least one copy of the SMN2 form that is necessary for survival, and 
disease severity depends primarily on the number of SMN2 gene copies. However, 
the number of SMN2 copies doesn’t explain completely the different severity of the 
disease observed in SMA patients.
In this work we compared by 2DE the fibroblasts proteomic patterns corresponding 
to several members of a SMA-carrier family (four sisters and their mother) and a group 
of four controls.
Among the family members, the four sisters have the same genotype but show 
different levels of disease severity (one of them is asymptomatic). The mother is 
heterozigous an thus asymptomatic. The analysis revealed the presence of 42 differential 
proteins between controls and patients with the SMA phenotype. Two other proteins 
were found differential between symptomatic and asymptomatic members of the 
family. A biological process analysis of the identified proteins reveals a high percentage 
of proteins classified as stress response and protein metabolism and modification. The 
functional implications of these proteins will be evaluated in future studies.
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